Access barriers to comprehensive care for people affected by tuberculosis and human immunodeficiency virus co-infection in Peru, 2010–2015

Translated English title: Access barriers to comprehensive care for people affected by tuberculosis and human immunodeficiency virus co-infection in Peru, 2010–2015<br />People infected with the human immunodeficiency virus (HIV) are 29 times more likely to develop tuberculosis than those who do not have HIV. Globally, the incidence of tuberculosis in people living with HIV (PLH) is 105.2 per 100 000 population, and in the Andean region of Latin America it is 118.4 per 100 000 population. The aim of this study is to identify the programmatic barriers that hinder access to comprehensive care of patients with tuberculosis and human immunodeficiency virus (TB/HIV) co-infection. In conclusion, there is poor coordination between HIV and TB health strategies. Management of TB/HIV co-infection is fragmented into different levels of care, which has an impact on comprehensive patient care. As a result of this research, a technical document was prepared to establish joint procedures that should be implemented to improve comprehensive care of TB/HIV co-infection.

a:1:{i:0;s:40:"https://dx.doi.org/10.26633/RPSP.2017.23";}

García-Fernández L, Benites C, Huamán B. Access barriers to comprehensive care for people affected by tuberculosis and human immunodeficiency virus co-infection in Peru, 2010–2015. Rev Panam Salud Publica. 2017;41(e23). doi:10.26633/RPSP.2017.23